Cultivation Technologies, Inc. Announces that the Staff of the Securities and Exchange Commission Has Concluded its Investigation with No Enforcement Action Recommended
IRVINE, CA / ACCESSWIRE / February 7, 2018 / Cultivation Technologies, Inc. ("CTI" or the "Company"), an emerging leader in medical cannabis cultivation, manufacturing, distribution, technology, and branding, received notice from the staff of the Securities and Exchange Commission ("SEC") that it has finalized its investigation of CTI and that it does not intend to recommend an enforcement action against the Company to the Commission. During the...
Read more








